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Abstract 
Objective:  To determine various modes of presentation 
of patients having epithelial ovarian carcinoma 
Study design and duration: This is a cross sectional 
study of observational type.Study consists on the 
duration of six months. 
Setting: This study was conducted in general surgical 
and chemotherapy ward of  Nishtar Hospital Multan. 
Patients and Methods:  All cases diagnosed with 
epithelial ovarian cancer presenting to the study 
institution during study period were included in this 
study. A performa was designed containing necessary 
questions like signs and symptoms at the time of first 
presentation, menopausal status, age of patient, family 
history of similar problem etc. Questions were asked in 
simplified way and their answers were noted down. 
Grade of tumors was also documented. All data collected 
was analyzed using SPSS and Microsoft office version 
2016. Results were calculated in the form of frequencies 
and percentages and averages. Tables and Graphs used to 
present data. Consent was taken from ethical committee 
of the study hospital and consent was also taken from all 
cases in study group.  
Results: Total 60 cases were included in the study. 5% 
cases were below 20 years age, 25% were between 20-30 
years, 16.7% between 30-40 years, 20% between 40-50 
years, 23.3% between 50-60 years and 10% cases were 
above 60 years of age. Mean age was 44.6 years. There 
was positive family history in 25% cases. 78.3% cases 
were in premenopausal and 21.7% in post menopausal 
status. There were 8.3% cases in first stage, 16.7% in 
second stage,55% in 3rd stage and 20% were in 4th stage 
of cancer at the time of presentation. Pathological grade 
reported was well differentiated in 30%, moderately 
differentiated in 41.7%, poorly differentiated in 18.3% 
and unknown grade in 10%.  
Conclusion: Epithelial ovarian cancer is mostly found in 
young women and usually is reported in late stages. High 
frequency of positive family history is found in these 
cases. 
Key Words:  epithelial ovarian cancer, clinical 
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INTRODUCTION 
Epithelial ovarian cancer is usually found in young 
female population. Such patients mostly have 
positive family history of similar or any other 
malignancy.1-5 So females with positive family 
history are at high risk. Usual presentation of these 
patients is abdominal pain, abdominal distension or 
abnormal bleeding from vagina etc. Mostly cases 
are in premenopausal period. CA 125 is tumor 
marker for epithelial ovarian carcinoma which is 
found raised in not all but most of the cases. BRCA 
gene mutation is associated with this tumor.6,7 This 
cancer accounts 90% of all ovarian cancers and a 
major cause of death from gynecological cancer.8-11 
It incidence is different in various races. It is very 
common in Africans and Caucasians. Its rate is 
high in industrialized states. Its incidence is rising 
each year.  It is common in post menopausal 
women mostly after 50 years of age. Reproductive 
factors like early menarche and late menopause are 
risk factors of this cancer. Other factors include 
nulliparity, lack of lactation, breast or endometrial 
cancer and family history of breast and ovarian 
cancer.12-15 
Patients and Methods 
This is a cross sectional study started in October 
2018 and completed in March 2019 after 6 months 
duration. Study was conducted in a tertiary care 
hospital Nishtar Hospital Multan. Cases were 
selected via randomized controlled trials. All cases 
diagnosed with epithelial ovarian cancer presenting 
to the study institution during study period were 
included in this study. A performa was designed 
containing necessary questions like signs and 
symptoms at the time of first presentation, 
menopausal status, age of patient, family history of 
similar problem etc. Questions were asked in 
simplified way and their answers were noted down. 
Grade of tumors was also documented. All data 
collected was analyzed using SPSS and Microsoft 
office version 2016. Results were calculated in the 
form of frequencies and percentages and averages. 
Tables and Graphs used to present data. Consent 
was taken from ethical committee of the study 
hospital and consent was also taken from all cases 
in study group. Privacy of data of all patiets in 
study group was maintained.  
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Results 
 Total 60 cases were included in the study. 3(5%) 
cases were below 20 years age, 15(25%) were 
between 20-30 years, 10(16.7%) between 30-40 
years, 12(20%) between 40-50 years, 14(23.3%) 
between 50-60 years and 6(10%) cases were above 
60 years of age. Mean age was 44.6 years. This is a 
cross sectional study started in October 2018 and 
completed in March 2019 after 6 months duration. 
Study was conducted in a tertiary care hospital 
Nishtar Hospital Multan. Cases were selected via 
randomized controlled trials. All cases diagnosed 
with epithelial ovarian cancer presenting to the 
study institution during study period were included 
in this study.  There was positive family history in 
25% cases. 47(78.3%) cases were in 
premenopausal and 13(21.7%) in post menopausal 
status. There were 5( 8.3%) cases in first stage, 
10(16.7%) in second stage, 33(55%) in 3rd stage 
and 12(20%) were in 4th stage of cancer at the time 
of presentation. Pathological grade reported was 
well differentiated in 18(30%), moderately 
differentiated in 25(41.7%), poorly differentiated in 
11(18.3%) and unknown grade in 6(10%).  
 
 
(Figure-1) frequency of presenting signs and symptoms among study group 
Discussion 
Ovarian cancer causes many deaths in America 
each year. It is a very common gynecological 
malignancy. Genes responsible for this malignancy 
are BRCA 1 and BRCA 2.15-18 Mutations of these 
genes cause ovarian cancer and other malignancies. 
Epithelial ovarian cancer is usually found in young 
female population. Such patients mostly have 
positive family history of similar or any other 
malignancy. So females with positive family 
history are at high risk. Usual presentation of these 
patients is abdominal pain, abdominal distension or 
abnormal bleeding from vagina etc.19 Mostly cases 
are in premenopausal period. CA 125 is tumor 
marker for epithelial ovarian carcinoma which is 
found raised in not all but most of the cases. BRCA 
gene mutation is associated with this tumor. This is 
a cross sectional study started in October 2018 and 
completed in March 2019 after 6 months duration. 
Study was conducted in a tertiary care hospital 
Nishtar Hospital Multan.20,21 Cases were selected 
via randomized controlled trials. All cases 
diagnosed with epithelial ovarian cancer presenting 
to the study institution during study period were 
included in this study.22-25 A performa was 
designed containing necessary questions like signs 
and symptoms at the time of first presentation, 
menopausal status, age of patient, family history of 
similar problem etc. This cancer accounts 90% of 
all ovarian cancers and a major cause of death from 
gynecological cancer. It incidence is different in 
various races. It is very common in Africans and 
Caucasians. Its rate is high in industrialized 
states.26-27 Its incidence is rising each year. There 
was positive family history in 25% cases. 
47(78.3%) cases were in premenopausal and 
13(21.7%) in post menopausal status. There were 
5( 8.3%) cases in first stage, 10(16.7%) in second 
stage, 33(55%) in 3rd stage and 12(20%) were in 4th 
stage of cancer at the time of presentation. 
Pathological grade reported was well differentiated 
in 18(30%), moderately differentiated in 
25(41.7%), poorly differentiated in 11(18.3%) and 
unknown grade in 6(10%).  It is common in post 
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menopausal women mostly after 50 years of age. . 
All data collected was analyzed using SPSS and 
Microsoft office version 2016. Results were 
calculated in the form of frequencies and 
percentages and averages. Tables and Graphs used 
to present data. Consent was taken from ethical 
committee of the study hospital and consent was 
also taken from all cases in study group. Privacy of 
data of all patiets in study group was maintained. 
Reproductive factors like early menarche and late 
menopause are risk factors of this cancer. Other 
factors include nulliparity, lack of lactation, breast 
or endometrial cancer and family history of breast 
and ovarian cancer. 
Conclusion: Epithelial ovarian cancer is mostly 
found in young women and usually is reported in 
late stages. High frequency of positive family 
history is found in these cases. 
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